HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). II. Hydrolysis by tissue homogenates and drug uptake by tumor cells in vitro.

Abstract
1-(2-Chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077) was hydrolyzed to its glucosyl metabolite TA-G by homogenates of guinea pig organs, rabbit VX-2 carcinoma and rat Yoshida sarcoma. The rate of TA-G formation by the kidney was the highest among the tissues examined and that by the diluted blood was undetectably low, reflecting their maltase activities. TA-077 was also hydrolyzed by suspensions of Yoshida sarcoma, AH130 hepatoma, L1210 leukemia, P388 leukemia and DBLA-10/C leukemia cells. The rate of TA-G formation was increased 10 fold by homogenizing the tumor cells. TA-G was taken up by the tumor cells much more efficiently than TA-077, explaining the higher sensitivities of the cultured tumor cells to TA-G than to TA-077. However, neither the maltase activity nor the membrane permeability to the drugs was a factor influential enough to explain the differences in drug sensitivity among the tumor cell lines.
AuthorsK Hayashida, K Oda, Y Akaike, Y Arai, S Takeyama
JournalJournal of pharmacobio-dynamics (J Pharmacobiodyn) Vol. 10 Issue 10 Pg. 515-22 (Oct 1987) ISSN: 0386-846X [Print] Japan
PMID3326928 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Glycoside Hydrolase Inhibitors
  • Nitrosourea Compounds
  • TA 077
  • alpha-Glucosidases
Topics
  • Animals
  • Antineoplastic Agents (blood, pharmacokinetics)
  • Female
  • Glycoside Hydrolase Inhibitors
  • Guinea Pigs
  • Hydrolysis
  • In Vitro Techniques
  • Male
  • Nitrosourea Compounds (blood, pharmacokinetics)
  • Rabbits
  • Tumor Cells, Cultured (metabolism)
  • alpha-Glucosidases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: